Ghent University Academic Bibliography

Prevention of cardiovascular and other systemic adverse outcomes in patients with asthma treated with biologics

Mohsen Sadatsafavi, Trung N. Tran, Ghislaine Scelo, Ming-Ju Tsai, John Busby, Benjamin Emmanuel, Liam G. Heaney, Christine Jenkins, Flavia Hoyte, Giorgio Walter Canonica, et al.

(2025) AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 211(7). p.1165-1174

Add to list

Journal Article
A1
open access

The epithelial era of asthma research : knowledge gaps and future direction for patient care

Christopher E. Brightling, Gianni Marone, Helena Catharine Aegerter (UGent) , Pascal Chanez, Enrico Heffler, Ian D. Pavord, Klaus F. Rabe, Lena Uller, Del Dorscheid and [ missing ] on behalf of the Epithelial Science Expert Group

(2024) EUROPEAN RESPIRATORY REVIEW. 33(174).

Add to list

Journal Article
A1
open access

EUFOREA/EPOS2020 statement on the clinical considerations for chronic rhinosinusitis with nasal polyps care

Peter Hellings (UGent) , Isam Alobid, Wilma T. Anselmo‐Lima, Manuel Bernal‐Sprekelsen, Leif Bjermer, Lisa Caulley, Adam Chaker, Jannis Constantinidis, Diego M. Conti, Eugenio De Corso, et al.

(2024) ALLERGY. 79(5). p.1123-1133

Add to list

Miscellaneous
open access

Rapid and sustained effects of dupilumab in severe chronic rhinosinusitis with nasal polyps

Peter Hellings (UGent) , Anju T Peters, Adam M Chaker, Enrico Heffler, Haixin Zhang, Amy Praestgaard, Scott Nash, Asif H. Khan, Shahid Siddiqui, Juby A Jacob-Nara, et al.

(2022) INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY. 12(7). p.958-962

Add to list

Journal Article
A1
open access

AROMA : real-world global registry of dupilumab for chronic rhinosinusitis with nasal polyps

Shahid Siddiqui, Claus Bachert (UGent) , Adam M. Chaker, Joseph K. Han, Peter Hellings (UGent) , Anju T. Peters, Enrico Heffler, Siddhesh Kamat, Haixin Zhang, Scott Nash, et al.

(2022) ERJ OPEN RESEARCH. 8(4).

Add to list

Responder analysis to demonstrate the effect of targeting type 2 inflammatory mechanisms with dupilumab across objective and patient‐reported endpoints for patients with severe chronic rhinosinusitis with nasal polyps in the SINUS‐24 and SINUS‐52 studies

Claus Bachert (UGent) , Anju T. Peters, Enrico Heffler, Joseph K. Han, Heidi Olze, Oliver Pfaar, Chien‐Chia Chuang, Raj Rout, Richa Attre, Ledia Goga, et al.

(2022) CLINICAL AND EXPERIMENTAL ALLERGY. 52(2). p.244-249

Add to list

Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps : a randomized, placebo-controlled trial

Claus Bachert (UGent) , Joseph K. Han, Martin Y. Desrosiers, Philippe Gevaert (UGent) , Enrico Heffler, Claire Hopkins, Jody R. Tversky, Peter Barker, David Cohen, Claire Emson, et al.

(2022) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 149(4). p.1309-1317.e12

Add to list

Journal Article
A1
open access

Estimating clinically meaningful change of efficacy outcomes in inadequately controlled chronic rhinosinusitis with nasal polyposis

Joseph K. Han, Claus Bachert (UGent) , Stella E. Lee, Claire Hopkins, Enrico Heffler, Peter Hellings (UGent) , Anju T. Peters, Siddhesh Kamat, Diane Whalley, Shanshan Qin, et al.

(2022) LARYNGOSCOPE. 132(2). p.265-271

Add to list

Journal Article
A1
open access

Indirect treatment comparison of biologics in chronic rhinosinusitis with nasal polyps

Anju T. Peters, Joseph K. Han, Peter Hellings (UGent) , Enrico Heffler, Philippe Gevaert (UGent) , Claus Bachert (UGent) , Yingxin Xu, Chien-Chia Chuang, Binod Neupane, Jérôme Msihid, et al.

(2021) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. 9(6). p.2461-2471.e5

Add to list

A responder analysis to demonstrate Dupilumab treatment effect across objective and patient-reported subjective endpoints for patients with severe chronic rhinosinusitis with nasal polyps (CRSwNP)

Claus Bachert (UGent) , Anju Peters, Enrico Heffler, Joseph Han, Heidi Olze, Oliver Pfaar, Chien-Chia Chuang, Raj Rout, Richa Attre, Ledia Goga, et al.

(2021) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. In Journal of Allergy and Clinical Immunology 147(2). p.AB132-AB132

Academic Bibliography

Prevention of cardiovascular and other systemic adverse outcomes in patients with asthma treated with biologics

The epithelial era of asthma research : knowledge gaps and future direction for patient care

EUFOREA/EPOS2020 statement on the clinical considerations for chronic rhinosinusitis with nasal polyps care

Rapid and sustained effects of dupilumab in severe chronic rhinosinusitis with nasal polyps

AROMA : real-world global registry of dupilumab for chronic rhinosinusitis with nasal polyps

Responder analysis to demonstrate the effect of targeting type 2 inflammatory mechanisms with dupilumab across objective and patient‐reported endpoints for patients with severe chronic rhinosinusitis with nasal polyps in the SINUS‐24 and SINUS‐52 studies

Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps : a randomized, placebo-controlled trial

Estimating clinically meaningful change of efficacy outcomes in inadequately controlled chronic rhinosinusitis with nasal polyposis

Indirect treatment comparison of biologics in chronic rhinosinusitis with nasal polyps

A responder analysis to demonstrate Dupilumab treatment effect across objective and patient-reported subjective endpoints for patients with severe chronic rhinosinusitis with nasal polyps (CRSwNP)

Contents

Support

Contact